Top Markets
Coin of the day
Relmada Therapeutics, Inc. Relmada Therapeutics, Inc.

Relmada Therapeutics, Inc.

RLMD
Peringkat dalam Saham #13829
Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company... Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States. The company focuses on the development of NDV-01, a controlled-release intravesical formulation of gemcitabine and docetaxel, which is in Phase 2 clinical trial for patients with aggressive forms of non-muscle invasive bladder cancer; and Sepranolone, a neurosteroid epimer of allopregnanolone, which is Phase 2b-ready for the potential treatment of prader-willi syndrome, tourette syndrome, excessive tremor, and other diseases related to excessive GABAergic activity. The company has an agreement with Asarina Pharma AB and Trigone. Relmada Therapeutics, Inc. was founded in 2004 and is headquartered in Coral Gables, Florida.
Harga Saham
$4.36
Kapitalisasi Pasar
$457.32M
Perubahan (1 hari)
0.69%
Perubahan (1 tahun)
289.29%
Negara
US
Perdagangan Relmada Therapeutics, Inc. (RLMD)

Kategori

Riwayat pemecahan saham untuk Relmada Therapeutics, Inc. (RLMD)
Saham Relmada Therapeutics, Inc. (simbol: RLMD) telah mengalami total 0 kali pemecahan saham.
Pemecahan saham terbaru terjadi pada Aug 31, 2026.
Satu lembar saham RLMD yang dibeli sebelum Aug 31, 2026 sekarang setara dengan 0 lembar saham RLMD.
Daftar pemecahan saham
Tahun Pemecahan Kelipatan Kelipatan Kumulatif
Tidak cukup data untuk tanggal yang disediakan.
Pemecahan saham untuk perusahaan sejenis atau pesaing
Perusahaan Jumlah pemecahan saham Kelipatan Kumulatif Negara
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH